ZB
RPRX icon

Zions Bancorporation’s Royalty Pharma RPRX Stock Holding History

Zions Bancorporation’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-37
Closed -$1.04K – 926
2023
Q4 		$1.04K Buy
+37
New +$1.02K ﹤0.01% 855
2023
Q3 		– Sell
-18
Closed -$553 – 915
2023
Q2 		$553 Buy
+18
New +$610 ﹤0.01% 868
2020
Q4 		– Sell
-157
Closed -$7K – 1017
2020
Q3 		$7K Buy
+157
New +$6.74K ﹤0.01% 762

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zions Bancorporation's RPRX Position: Q1 2024 in Review

Zions Bancorporation sold out of Royalty Pharma (RPRX) in Q1 2024, closing a stake of 37 shares — an estimated $1.04K sold.

Zions Bancorporation first reported a position in RPRX in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q3 2020. 378 funds tracked by Wall St. Rank hold RPRX as of Q1 2024.

  • Zions Bancorporation reported no remaining Royalty Pharma position as of Q1 2024 after selling out during the quarter.
  • Zions Bancorporation sold 37 Royalty Pharma shares in Q1 2024, an estimated $1.04K.
  • Zions Bancorporation first reported a position in Royalty Pharma in Q3 2020 and held it in 3 quarters.
  • Zions Bancorporation's Royalty Pharma position peaked at $7K in Q3 2020.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2024.

Based on Zions Bancorporation's 13F filing for Q1 2024, filed 14 May 2024.